Anavex Life Sciences Corp (AVXL)

[apostrophe]

re: New 23andME oral swab Alzheimer's test

“We have patients that do get Alzheimer's and don't have the genetic marker and we have other patients that don't get Alzheimer's and have that genetic marker,” says Dr. Kerwin, “so it's not a guarantee and people really need to understand that.”

Not a lot of certainty there. But, nevertheless, because Anavex 2-73 is proven to do no harm in healthy volunteers, one can imagine this development solidifying a potentially huge future prevention market, likely even bigger than the present confirmed market.

Big pharma has been credited with the invention of the $1000 pill. We haven't seen cost figures for 2-73 but going by the trials so far, the modest costs suggest that 2-73 can be produced at a price that people can afford.

With the right manufacturing and distribution partner, the cost theoretically can be made even more reasonable with economies of scale and still allow Anavex to make a good profit. All the while saving the health care system from going bust.